164 related articles for article (PubMed ID: 11747721)
21. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants?
He Q; Mäkinen J; Berbers G; Mooi FR; Viljanen MK; Arvilommi H; Mertsola J
J Infect Dis; 2003 Apr; 187(8):1200-5. PubMed ID: 12695998
[TBL] [Abstract][Full Text] [Related]
22. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.
Buasri W; Impoolsup A; Boonchird C; Luengchaichawange A; Prompiboon P; Petre J; Panbangred W
BMC Microbiol; 2012 Apr; 12():61. PubMed ID: 22524455
[TBL] [Abstract][Full Text] [Related]
23. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA
Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
[TBL] [Abstract][Full Text] [Related]
24. Misidentification of Bordetella bronchiseptica as Bordetella pertussis using a newly described real-time PCR targeting the pertactin gene.
Register KB; Nicholson TL
J Med Microbiol; 2007 Dec; 56(Pt 12):1608-1610. PubMed ID: 18033827
[TBL] [Abstract][Full Text] [Related]
25. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
[TBL] [Abstract][Full Text] [Related]
26. Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom.
Fry NK; Neal S; Harrison TG; Miller E; Matthews R; George RC
Infect Immun; 2001 Sep; 69(9):5520-8. PubMed ID: 11500425
[TBL] [Abstract][Full Text] [Related]
27. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
[TBL] [Abstract][Full Text] [Related]
28. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
Tsang RS; Sill ML; Martin IE; Jamieson F
Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
[TBL] [Abstract][Full Text] [Related]
29. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.
Mooi FR; van Oirschot H; Heuvelman K; van der Heide HG; Gaastra W; Willems RJ
Infect Immun; 1998 Feb; 66(2):670-5. PubMed ID: 9453625
[TBL] [Abstract][Full Text] [Related]
30. The new strategy for allele identification of the genes coding for pertussis toxin subunit S1 (ptx S1) and pertactin (prn) in Bordetella pertussis.
Fiett J; Letowska I; Gniadkowski M; Hryniewicz W
J Microbiol Methods; 2003 Dec; 55(3):651-66. PubMed ID: 14607408
[TBL] [Abstract][Full Text] [Related]
31. Hybrid genes over-express pertactin from Bordetella pertussis.
Loosmore SM; Yacoob RK; Zealey GR; Jackson GE; Yang YP; Chong PS; Shortreed JM; Coleman DC; Cunningham JD; Gisonni L
Vaccine; 1995 Apr; 13(6):571-80. PubMed ID: 7483778
[TBL] [Abstract][Full Text] [Related]
32. [Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?].
Zavadilová J; Lžičařová D; Musílek M; Křížová P; Fabiánová K
Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):130-8. PubMed ID: 26448300
[TBL] [Abstract][Full Text] [Related]
33. The evolving nature of
Tsang RSW; Shuel M; Cronin K; Deng S; Whyte K; Marchand-Austin A; Ma J; Bolotin S; Crowcroft N; Schwartz K; Van Domselaar G; Graham M; Jamieson FB
Can J Microbiol; 2019 Nov; 65(11):823-830. PubMed ID: 31295416
[TBL] [Abstract][Full Text] [Related]
34. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process].
Mazurova IK; Borisova OIu; Kombarova SIu; Zakharova NS; Aleshkin VA
Mol Gen Mikrobiol Virusol; 2005; (4):21-5. PubMed ID: 16334221
[TBL] [Abstract][Full Text] [Related]
35. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
[TBL] [Abstract][Full Text] [Related]
36. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
Bouchez V; Brun D; Cantinelli T; Dore G; Njamkepo E; Guiso N
Vaccine; 2009 Oct; 27(43):6034-41. PubMed ID: 19666155
[TBL] [Abstract][Full Text] [Related]
37. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N; Guiso N
Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
[TBL] [Abstract][Full Text] [Related]
38. Naturally circulating pertactin-deficient
Kroes MM; Miranda-Bedate A; Hovingh ES; Jacobi R; Schot C; Pupo E; Raeven RHM; van der Ark AAJ; van Putten JPM; de Wit J; Mariman R; Pinelli E
Emerg Microbes Infect; 2021 Dec; 10(1):1358-1368. PubMed ID: 34132167
[TBL] [Abstract][Full Text] [Related]
39. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
[TBL] [Abstract][Full Text] [Related]
40. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
